Over 45 researchers and senior management attended ACTI’s highly successful China Healthcare Market Bootcamp, held at Macquarie University’s Sydney CBD Campus. Attendees included representatives from some of New South Wales’ most prestigious research organisations and medtech companies, including Garvan Institute, Macquarie University, Children’s Medical Research Institute, University of Sydney and UNSW.
The Australia China Technology Incubator (ACTI) is a Federal Government initiative designed to provide medtech and broader healthcare company CEOs and senior executives the knowledge needed to develop a successful market entry strategy for China.
The Bootcamp was strongly supported by New South Wales State Government and opened by Ms Kim Curtain, Deputy Secretary, Department of Industry, Investments, Tourism & Precincts and included presentations by ACTI Founder Rob Scott and the CEO of Shanghai’s largest life science and medtech incubator Joyin Innovation & Manufacturing Center – Cyndi Zhai, Brandwood CMC, FB Rice, Dentons and other experienced China market professionals.
These presenters passed on their China market knowledge and experience during sessions including developing a China market entry strategy; successful partnering approaches; regulatory pathways; distribution and marketing; market risks; common mistakes; and key success factors for Australian healthcare products, technologies, and services looking to access the growing China market.
With China now the second largest healthcare market and rapidly emerging as a driver of growth in biotechnology research and investment, these ACTI Bootcamps provide a critical opportunity for Australian life science companies to present their business case and leverage the booming China market opportunity for Australian medtech and diagnostic companies.
ACTI is currently halfway through its two-year mission of evaluating, educating, and assisting more than 200 Australian medtech and diagnostic companies wanting to enter the Chinese market. ACTI’s combined incubator and market accelerator model provides much needed skills, knowledge, and experience to Australian science entrepreneurs through its 3-month intensive China-based residency program at the Joyin/HiMed facility in Zhangjiang.
ACTI has confirmed it will be conducting further events, including Bootcamps in regional centres in NSW, Queensland, and Victoria, throughout the remainder of 2019 and during 2020 to raise awareness of the growing opportunities in the Chinese healthcare sector for Australian medtech and diagnostic technologies.
Media Details – Mr Melvin Lee, Incubator Manager, ACTI. Email: melvin@acti.asia.
© 2019 www.acti.asia